The safety of TNF-α inhibitors during pregnancy has been extensively studied in other contexts, such as RA and IBD, where these drugs have demonstrated no significant increase in spontaneous abortion or adverse pregnancy outcomes. This evidence concerns the gene TNF and inflammatory bowel disease.